Garcia, Jacob
Bristol-Myers Squibb (United States) · Juno Therapeutics (United States)
2 papers on CoChat
Most cited papers
- Verified
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
Abramson, J. S., Palomba, M. L., Gordon, L. I., Lunning, M. A., Wang, M., Arnason, J., Mehta, A., Purev, E., Maloney, D. G., Andreadis, C., et al. (2020) · The Lancet
CAR-T cell therapy researchLymphoma Diagnosis and Treatment
Cited by 2,430
- Verified
Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study
Ndila, C. M., Uyoga, S., Macharia, A. W., Nyutu, G., Peshu, N., Ojal, J., Shebe, M., Awuondo, K. O., Mturi, N., Tsofa, B., et al. (2018) · The Lancet Haematology
Malaria Research and ControlHemoglobinopathies and Related Disorders
Cited by 108
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free